Arama Sonuçları - Heinz-A. Horst

Sonuçları Daraltın
  1. 1
    Phase II Study of Vicriviroc versus Efavirenz (both with Zidovudine/Lamivudine) in Treatment‐Naive Subjects with HIV‐1 Infection

    Phase II Study of Vicriviroc versus Efavirenz (both with Zidovudine/Lamivudine) in Treatment‐Naive Subjects with HIV‐1 Infection Yazar: Raphael J. Landovitz, Jonathan B. Angel, Christian Hoffmann, Heinz A. Horst, Milos Opravil, Jianmin Long, Wayne Greaves, Gerd Fätkenheuer

    Baskı/Yayın Bilgisi 2008
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia

    Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia Yazar: Nicola Gökbuget, Gerhard Zugmaier, Matthias Klinger, Peter Kufer, Matthias Stelljes, Andreas Viardot, Heinz A. Horst, Svenja Neumann, Monika Brüggemann, Oliver G. Ottmann, Thomas Burmeister, Dorothea Wessiepe, Max S. Topp, Ralf C. Bargou

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim
    Carta
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Long-term survival and T-cell kinetics in relapsed/refractory ALL patients who achieved MRD response after blinatumomab treatment

    Long-term survival and T-cell kinetics in relapsed/refractory ALL patients who achieved MRD response after blinatumomab treatment Yazar: Gerhard Zugmaier, Nicola Gökbuget, Matthias Klinger, Andreas Viardot, Matthias Stelljes, Svenja Neumann, Heinz-A. Horst, Reinhard Marks, Christoph Faul, H. Diedrich, Albrecht Reichle, Monika Brüggemann, Chris Holland, Margit Schmidt, Hermann Einsele, Ralf C. Bargou, Max S. Topp

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Prospective Evaluation of Allogeneic Hematopoietic Stem-Cell Transplantation From Matched Related and Matched Unrelated Donors in Younger Adults With High-Risk Acute Myeloid Leukemia: German-Austrian Trial AMLHD98A

    Prospective Evaluation of Allogeneic Hematopoietic Stem-Cell Transplantation From Matched Related and Matched Unrelated Donors in Younger Adults With High-Risk Acute Myeloid Leukem... Yazar: Richard F. Schlenk, Konstanze Döhner, Silja Mack, Michael Stoppel, Franz J. Király, Katharina S. Götze, Frank Hartmann, Heinz A. Horst, Elisabeth Koller, Andreas Petzer, W. Grimminger, Guido Kobbe, Axel Glasmacher, Hans Salwender, Heinz Kirchen, Detlef Haase, Stephan Kremers, Axel Matzdorff, Axel Benner, Hartmut Döhner

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)

    Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial) Yazar: Oliver A. Cornely, Johan Maertens, Mark Bresnik, Ramin Ebrahimi, Andrew J. Ullmann, Emilio Bouza, Claus Peter Heußel, O. Lortholary, C. Rieger, Angelika Boehme, M. Aoun, Heinz A. Horst, Anne Thiébaut, Markus Ruhnke, Dietmar Reichert, Nicola Vianelli, Stefan W. Krause, Eduardo Olavarría, Raoul Herbrecht

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  6. 6
    <i>RUNX1</i> Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group

    <i>RUNX1</i> Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group Yazar: Verena I. Gaidzik, Lars Bullinger, Richard F. Schlenk, Andreas Zimmermann, Jürgen Röck, Peter Paschka, Andrea Corbacioglu, Jürgen Krauter, Brigitte Schlegelberger, Arnold Ganser, Daniela Späth, Andrea Kündgen, Ingo G.H. Schmidt‐Wolf, Katharina S. Götze, David Nachbaur, Michael Pfreundschuh, Heinz A. Horst, Hartmut Döhner, Konstanze Döhner

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies

    Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies Yazar: Sabine Käyser, Manuela Zucknick, Konstanze Döhner, Jürgen Krauter, Claus‐Henning Köhne, Heinz A. Horst, Gerhard Held, Marie von Lilienfeld‐Toal, Sibylla Wilhelm, Mathias Rummel, Ulrich Germing, Katharina S. Götze, David Nachbaur, Brigitte Schlegelberger, Gudrun Göhring, Daniela Späth, Carina Morlok, Veronica Teleanu, Arnold Ganser, Hartmut Döhner, Richard F. Schlenk

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial)

    Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial) Yazar: Hans‐Jürgen Stellbrink, Jan van Lunzen, Michael Westby, Eithne O’Sullivan, Claus Schneider, Axel Adam, Lutwin Weitner, Birger Kuhlmann, Christian Hoffmann, Stefan Fenske, Philipp S. Aries, Olaf Degen, Christian Eggers, H. Petersen, Friedrich Haag, Heinz A. Horst, K. Dalhoff, Christiane Möcklinghoff, Nick Cammack, Klara Tenner‐Racz, Paul Rácz

    Baskı/Yayın Bilgisi 2002
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study Group

    ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study Group Yazar: Peter Paschka, R. Schlenk, Verena I. Gaidzik, Julia Herzig, Teresa Aulitzky, Lars Bullinger, Daniela Späth, Veronica Teleanu, Andrea Kündgen, C.-H. Köhne, Peter Brossart, Gerhard Held, Heinz A. Horst, Mark Ringhoffer, Katharina S. Götze, David Nachbaur, Thomas Kindler, Michael Heuser, F. Thol, Arnold Ganser, Hartmut Döhner, Konstanze Döhner

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group

    Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group Yazar: Eva Lengfelder, Benjamin Hanfstein, Claudia Haferlach, Jan Braess, Utz Krug, Karsten Spiekermann, Torsten Haferlach, Karl‐Anton Kreuzer, Hubert Serve, Heinz A. Horst, Susanne Schnittger, Carlo Aul, Beate Schultheis, Philipp Erben, Stephanie Schneider, Carsten Müller‐Tidow, Bernhard Wörmann, Wolfgang E. Berdel, Cristina Sauerland, Achim Heinecke, Rüdiger Hehlmann, Wolf‐Karsten Hofmann, Wolfgang Hiddemann, Thomas Büchner

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20-Positive B Cell PTLD: Clues From the PTLD-1 Trial

    International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20-Positive B Cell PTLD: Clues From the PTLD-1... Yazar: Ralf Ulrich Trappe, Sylvain Choquet, Daan Dierickx, Peter Mollee, Jan Maciej Zaucha, Martin Dreyling, Ulrich Dührsen, Corrado Tarella, Ofer Shpilberg, Monica Sender, Gilles Salles, Franck Morschhauser, Arnaud Jaccard, T. Lamy, Petra Reinke, R. Neuhaus, H. Lehmkuhl, Heinz A. Horst, Malte Leithäuser, Peter Schlattmann, Ioannis Anagnostopoulos, Martine Raphaël, Hanno Riess, V. Leblond, Stephan Oertel

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients

    Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients Yazar: Michela Tassara, Konstanze Döhner, Peter Brossart, Gerhard Held, Katharina S. Götze, Heinz-A. Horst, Mark Ringhoffer, Claus‐Henning Köhne, Stephan Kremers, Aruna Raghavachar, Gerald Wulf, Heinz Kirchen, David Nachbaur, Hans Günter Derigs, Mohammed Wattad, Elisabeth Koller, Wolfram Brugger, Axel Matzdorff, Richard Greil, Gerhard Heil, Peter Paschka, Verena I. Gaidzik, Martin Göttlicher, Hartmut Döhner, Richard F Schlenk

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation

    Differential impact of allelic ratio and insertion site in FLT3-ITD–positive AML with respect to allogeneic transplantation Yazar: Richard F. Schlenk, Sabine Käyser, Lars Bullinger, Guido Kobbe, Jochen Casper, Mark Ringhoffer, Gerhard Held, Peter Brossart, Michael Lübbert, Helmut R. Salih, Thomas Kindler, Heinz A. Horst, Gerald Wulf, David Nachbaur, Katharina S. Götze, Alexander Lamparter, Peter Paschka, Verena I. Gaidzik, Veronica Teleanu, Daniela Späth, Axel Benner, Jürgen Krauter, Arnold Ganser, Hartmut Döhner, Konstanze Döhner

    Baskı/Yayın Bilgisi 2014
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL

    Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL Yazar: Max S. Topp, Nicola Gökbuget, Gerhard Zugmaier, Evelyn Degenhard, Marie-Elisabeth Goebeler, Matthias Klinger, Svenja Neumann, Heinz A. Horst, Thorsten Raff, Andreas Viardot, Matthias Stelljes, Markus Schaich, R Köhne-Volland, Monika Brüggemann, Oliver G. Ottmann, Thomas Burmeister, Patrick A. Baeuerle, Dirk Nagorsen, Margit Schmidt, Hermann Einsele, Gert Riethmüller, Michael Kneba, Dieter Hoelzer, Peter Kufer, Ralf C. Bargou

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study

    All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study Yazar: Richard F. Schlenk, Michael Lübbert, Axel Benner, Alexander Lamparter, Jürgen Krauter, Wolfgang Herr, Hans Martin, Helmut R. Salih, Andrea Kündgen, Heinz-A. Horst, Peter Brossart, Katharina S. Götze, David Nachbaur, Mohammed Wattad, Claus‐Henning Köhne, Walter Fiedler, Martin Bentz, Gerald Wulf, Gerhard Held, Bernd Hertenstein, Hans Salwender, Verena I. Gaidzik, Brigitte Schlegelberger, Daniela Weber, Konstanze Döhner, Arnold Ganser, Hartmut Döhner

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival

    Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in Hi... Yazar: Max S. Topp, Peter Kufer, Nicola Gökbuget, Mariele Goebeler, Matthias Klinger, Svenja Neumann, Heinz-A. Horst, Thorsten Raff, Andreas Viardot, Mathias Schmid, Matthias Stelljes, Markus Schaich, Evelyn Degenhard, R Köhne-Volland, Monika Brüggemann, Oliver G. Ottmann, Roman Pfeifer, Thomas Burmeister, Dirk Nagorsen, Margit Schmidt, Ralf Lutterbuese, Carsten Reinhardt, Patrick A. Baeuerle, Michael Kneba, Hermann Einsele, Gert Riethmüller, Dieter Hoelzer, Gerhard Zugmaier, Ralf C. Bargou

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group

    Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group Yazar: Frank G. Rücker, Mridul Agrawal, Andrea Corbacioglu, Daniela Weber, Silke Kapp‐Schwoerer, Verena I. Gaidzik, Nikolaus Jahn, Thomas Schroeder, Mohammed Wattad, Michael Lübbert, Elisabeth Koller, Thomas Kindler, Katharina S. Götze, Mark Ringhoffer, Jörg Westermann, Walter Fiedler, Heinz A. Horst, Richard Greil, Roland Schroers, Karin Mayer, Thomas Heinicke, Jürgen Krauter, Richard F. Schlenk, Felicitas Thol, Michael Heuser, Arnold Ganser, Lars Bullinger, Peter Paschka, Hartmut Döhner, Konstanze Döhner

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)

    Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO) Yazar: Gabriele Nagel, Daniela Weber, Ella Fromm, Sophie Erhardt, Michael Lübbert, Walter Fiedler, Thomas Kindler, J. Krauter, Peter Brossart, Andrea Kündgen, Helmut R. Salih, Jörg Westermann, Gerald Wulf, Bernd Hertenstein, Mohammed Wattad, Katharina S. Götze, Doris Kraemer, Thomas Heinicke, Michael Girschikofsky, Hans-Günter Derigs, Heinz A. Horst, Christiane Rudolph, Michael Heuser, Gudrun Göhring, Veronica Teleanu, Lars Bullinger, Felicitas Thol, Verena I. Gaidzik, Peter Paschka, Konstanze Döhner, Arnold Ganser, Hartmut Döhner, Richard F. Schlenk

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Gemtuzumab Ozogamicin in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study

    Gemtuzumab Ozogamicin in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study Yazar: Richard F. Schlenk, Peter Paschka, Julia Krzykalla, Daniela Weber, Silke Kapp‐Schwoerer, Verena I. Gaidzik, Claudia Leis, Walter Fiedler, Thomas Kindler, Thomas Schroeder, Karin Mayer, Michael Lübbert, Mohammed Wattad, Katharina S. Götze, Heinz A. Horst, Elisabeth Koller, Gerald Wulf, Jan Schleicher, Martin Bentz, Richard Greil, Bernd Hertenstein, Jürgen Krauter, Uwe M. Martens, David Nachbaur, Maisun Abu Samra, Michael Girschikofsky, Nadežda Basara, Axel Benner, Felicitas Thol, Michael Heuser, Arnold Ganser, Konstanze Döhner, Hartmut Döhner

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Clinical, Molecular, and Prognostic Significance of WHO Type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and Various Other 3q Abnormalities in Acute Myeloid Leukemia

    Clinical, Molecular, and Prognostic Significance of WHO Type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and Various Other 3q Abnormalities in Acute Myeloid Leukemia Yazar: Sanne Lugthart, Stefan Gröschel, H. Berna Beverloo, Sabine Käyser, Peter J.M. Valk, Shama L. van Zelderen‐Bhola, Gert J. Ossenkoppele, Edo Vellenga, Eva van den Berg-de Ruiter, Urs Schanz, Gregor Verhoef, Peter Vandenberghe, Augustin Ferrant, Claus‐Henning Köhne, Michael Pfreundschuh, Heinz A. Horst, Elisabeth Koller, Marie von Lilienfeld‐Toal, Martin Bentz, Arnold Ganser, Brigitte Schlegelberger, Martine Jotterand, Jürgen Krauter, Thomas Pabst, Matthias Theobald, Richard F. Schlenk, Ruud Delwel, Konstanze Döhner, Bob Löwenberg, Hartmut Döhner

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: